Recognising excellence in global, regional and local markets to improve patient outcomes
| Entry deadline | 29 August 2025 |
| Extended entry deadline: | 5 September 2025, additional fee applies |
| Judging day | 10 October 2025 |
| Awards Ceremony | 19 November 2025 |
Welcome to the PMEA Awards
What is the PMEA programme?
PMEA rewards responsible customer-centric business practices that ensure treatments and advice provide patients with meaningful outcomes, recognising excellence in global, regional and local work.
It reflects the dynamic healthcare environment and the industry’s development of new, intelligent ways to improve patient care and outcomes and provide greater value for healthcare providers and payers.
Each year the categories and programme are scrutinised to ensure that PMEA continues to be specifically designed to recognise and commend excellence, best practice and innovation in European, international and local markets. For 2025, the judging criteria and categories have once again been refined.
Entry period
PMEA 2025 entry period is from January 2024 – June 2025 unless otherwise stated in the category description.
Entering
For PMEA 2025 once again the online entry system https://pmea.awardsplatform.com/ is being used for entrants.
Results 2025
PMEA 2025 aims to…
1. Recognise work that delivers clearly identifiable benefits and improved outcomes for patients and societal value in global, regional and local markets.
2. Recognise the value of responsible business practice that improve:
- Standards of clinical practice
- Provision of healthcare
- Access to medical treatment or services
- Uptake of treatment
- Adherence and compliance with treatment
- Coordination and delivery of services
- Treatment benefits
- Support for independence and management of risk
3. Identify and recognise the talented organisations behind the work.
4. Create an environment where success is valued and commended.
Why enter PMEA?
Good work shouldn’t go unrecognised! Don’t miss your chance to be singled out for excellence in improving patient outcomes by a panel of experienced, independent industry judges. Being recognised through the PMEA programme is regarded as a significant achievement for the teams, companies, agencies and consultancies behind the initiatives.
Success at PMEA can be a key driver for business growth and for building morale with internal and external stakeholders alike.
Who can enter?
- European, international or UK pharmaceutical, biotech, ethical, life science, OTC and medical device/diagnostic companies
- Healthcare agencies and consultancies, based in Europe, internationally or the UK
- Management consultants acting on behalf (and with the full authorisation) of the client pharmaceutical company
- Patient associations and charities
- NHS or similar European/International organisations.
- Trade organisations and professional bodies.
- Private Healthcare Providers, Private Insurers, Self-Pay Companies based in Europe, Internationally or UK.
PMEA offers pharma/biotech companies, healthcare charities and their supporting partners/ agencies across many different sectors and geographies the unique opportunity to showcase the quality and effectiveness of your work whilst retaining the highest standards of ethics and confidentiality. We have created a series of categories to stimulate entries from a wide range of programmes and organisations – with global, regional and local scale – united in a desire to improve or transform patient outcomes. These awards showcase the industry’s great thinking, use of technology, innovation and collaboration. We welcome entries at global, regional and national levels, across different therapeutic areas and organisations – large or small. We have created an easy process and clear entry criteria to encourage you to “put yourself out there”… see what happens. Good luck to all teams and organisations in 2025!
